Browsing by subject "Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group"
Now showing items 1-1 of 1
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma. (2019-11)Objective Current strategies to guide selection of neoadjuvant therapy in oesophageal adenocarcinoma (OAC) are inadequate. We assessed the ability of a DNA damage immune response (DDIR) assay to predict response following ...